Geriatric medicine Archives

Videos

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

Videos

ENSURE – The role of early intervention in muscle health

In this Product Explainer Geriatrician A/Prof Solomon Yu explains the importance of integrating muscle health screening, diagnosis and management in routine clinical practice, and the role of early intervention including HMB enriched oral nutritional supplementation for preventing and reversing sarcopenia.

Clinical Articles

Shingrix FAQ

From 1 November, Shingrix will replace Zostavax on the National Immunisation Program (NIP), with free coverage expanded to people aged ≥65 and First Nations people aged ≥50, as well as immunocompromised people with certain medical conditions who are aged ≥18.

Learning Modules

On-Demand Seminar | Women’s & Children’s Health Update 2023

This value-packed online learning module features a high-quality educational programme presented by leading experts focusing on practical clinical issues you face daily.

Clinical Articles

Mild cognitive impairment: Individualising screening and treatment

Half of patients with MCI develop dementia within five years — Here’s how we can help change that trajectory...

Clinical Articles

Topical NSAIDs come out on top for osteoarthritis, but guidelines lag

Topical NSAIDs come out on top for osteoarthritis and musculoskeletal pain, but not all guidelines reflect the evidence

Clinical Articles

Major changes to shingles vaccine program announced

Health minister Mark Butler endorsed the Pharmaceutical Benefit Advisory Committee's recommendation to fund Shingrix on the National Immunisation Programme (NIP)

Clinical Articles

Dementia & MHT – Cause or correlation?

A Danish study has linked HRT to dementia, but experts say the research is far from clearcut

Videos

Influenza vaccines for older adults in the 2023 influenza season

In this Product Explainer, Public Health Physician A/Prof John Litt AM explains the currently funded adjuvanted quadrivalent influenza vaccine for people 65 years and over and how it fits in the 2023 influenza season (6 mins). This product explainer is supported by Seqirus

Learning Modules

Dementia Prevention in Primary Care – A Mini Audit

This activity will focus on dementia prevention in primary care and will involve sending a link to a standardised questionnaire (CogDrisk) aimed at calculating a risk profile and identifying modifiable risk factors for dementia to all your patients between age 45-65, discussing the results with your patients and reporting on the outcomes in the report template provided.

Expert/s: Healthed

Videos

Souvenaid – the role of a medical food to support memory and cognitive function in patients in the early stages of alzheimer’s disease

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains the evidence for Souvenaid, a medical food, to support memory and cognitive function in patients in the early stages of Alzheimer's disease (5 mins).

Videos

Sarcopenia and the role of HMB enriched oral nutritional supplementation

In this Product Explainer Prof Robin Daly, Chair of Exercise & Ageing, Deakin University explains how a HMB enriched oral nutritional supplementation can help to protect muscle mass, strength, and function, and its potential role in the management of sarcopenia (5 mins).

Geriatric medicine

Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹

ENSURE – The role of early intervention in muscle health

Shingrix FAQ

From 1 November, Shingrix will replace Zostavax on the National Immunisation Program (NIP), with free coverage expanded to people aged ≥65 and First Nations people aged ≥50, as well as immunocompromised people with certain medical conditions who are aged ≥18.

On-Demand Seminar | Women’s & Children’s Health Update 2023

This value-packed online learning module features a high-quality educational programme presented by leading experts focusing on practical clinical issues you face daily.

Mild cognitive impairment: Individualising screening and treatment

Half of patients with MCI develop dementia within five years — Here’s how we can help change that trajectory...

Topical NSAIDs come out on top for osteoarthritis, but guidelines lag

Topical NSAIDs come out on top for osteoarthritis and musculoskeletal pain, but not all guidelines reflect the evidence

Major changes to shingles vaccine program announced

Health minister Mark Butler endorsed the Pharmaceutical Benefit Advisory Committee's recommendation to fund Shingrix on the National Immunisation Programme (NIP)

Dementia & MHT – Cause or correlation?

A Danish study has linked HRT to dementia, but experts say the research is far from clearcut

Influenza vaccines for older adults in the 2023 influenza season

In this Product Explainer, Public Health Physician A/Prof John Litt AM explains the currently funded adjuvanted quadrivalent influenza vaccine for people 65 years and over and how it fits in the 2023 influenza season (6 mins). This product explainer is supported by Seqirus

Dementia Prevention in Primary Care – A Mini Audit

Souvenaid – the role of a medical food to support memory and cognitive function in patients in the early stages of alzheimer’s disease

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains the evidence for Souvenaid, a medical food, to support memory and cognitive function in patients in the early stages of Alzheimer's disease (5 mins).

Sarcopenia and the role of HMB enriched oral nutritional supplementation

In this Product Explainer Prof Robin Daly, Chair of Exercise & Ageing, Deakin University explains how a HMB enriched oral nutritional supplementation can help to protect muscle mass, strength, and function, and its potential role in the management of sarcopenia (5 mins).

Get the app

Site

Company

Connect

Legal

Healthed

Geriatric medicine

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1

From 1 November, Shingrix will replace Zostavax on the National Immunisation Program (NIP), with free coverage expanded to people aged ≥65 and First Nations people aged ≥50, as well as immunocompromised people with certain medical conditions who are aged ≥18.

This value-packed online learning module features a high-quality educational programme presented by leading experts focusing on practical clinical issues you face daily.

Half of patients with MCI develop dementia within five years — Here’s how we can help change that trajectory...

Topical NSAIDs come out on top for osteoarthritis and musculoskeletal pain, but not all guidelines reflect the evidence

Health minister Mark Butler endorsed the Pharmaceutical Benefit Advisory Committee's recommendation to fund Shingrix on the National Immunisation Programme (NIP)

A Danish study has linked HRT to dementia, but experts say the research is far from clearcut

In this Product Explainer, Public Health Physician A/Prof John Litt AM explains the currently funded adjuvanted quadrivalent influenza vaccine for people 65 years and over and how it fits in the 2023 influenza season (6 mins). This product explainer is supported by Seqirus

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains the evidence for Souvenaid, a medical food, to support memory and cognitive function in patients in the early stages of Alzheimer's disease (5 mins).

In this Product Explainer Prof Robin Daly, Chair of Exercise & Ageing, Deakin University explains how a HMB enriched oral nutritional supplementation can help to protect muscle mass, strength, and function, and its potential role in the management of sarcopenia (5 mins).

Get the app

Site

Company

Connect

Legal

Extra Details

Healthed

In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).¹